clofibrate has been researched along with Brain Vascular Disorders in 27 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Excerpt | Relevance | Reference |
---|
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (92.59) | 18.7374 |
1990's | 1 (3.70) | 18.2507 |
2000's | 1 (3.70) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
OLIVER, MF | 2 |
Fujioka, T | 1 |
Ueno, T | 1 |
Matsumoto, T | 1 |
Watanabe, H | 1 |
Bousser, MG | 1 |
Lechner, H | 1 |
Ott, E | 1 |
Bertha, G | 1 |
Hanefeld, M | 1 |
Hora, C | 1 |
Schulze, J | 1 |
Rothe, G | 1 |
Barthel, U | 1 |
Haller, H | 1 |
Birgens, HS | 1 |
Hansen, MS | 1 |
Hirsh, J | 5 |
Cristol, R | 1 |
Olivella, J | 1 |
Vicens, B | 1 |
Turpie, AG | 2 |
Smith, GD | 1 |
Egger, M | 1 |
Sheldon, TA | 1 |
Weiss, HJ | 1 |
Dettori, AG | 1 |
Pini, M | 1 |
Quintavalla, R | 1 |
Gantmacher, ML | 1 |
Blakely, JA | 1 |
Harker, LA | 2 |
Gent, M | 3 |
Genton, E | 3 |
Aledort, LM | 1 |
Zöllner, N | 1 |
Keller, C | 1 |
Wolfram, G | 1 |
Parsons, WB | 1 |
Miettinen, TA | 1 |
Huttunen, JK | 1 |
Naukkarinen, V | 1 |
Strandberg, T | 1 |
Vanhanen, H | 1 |
Hirsch, SB | 1 |
Wechsler, AF | 1 |
Tourtellotte, WW | 1 |
Hammer, O | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00000482] | Phase 3 | 0 participants | Interventional | 1965-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
14 reviews available for clofibrate and Brain Vascular Disorders
Article | Year |
---|---|
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronar | 2004 |
Strategy of reducing coronary risk and the use of drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Cerebrovascular Disorders; Cholesterol; Clofibra | 1984 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofib | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggrega | 1983 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Hea | 1981 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dext | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
10 trials available for clofibrate and Brain Vascular Disorders
Article | Year |
---|---|
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofib | 1983 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
Plafibride: clinical trial of a new platelet antiaggregating agent.
Topics: Adenosine Diphosphate; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Clofib | 1981 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical T | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Clofibrate and niacin in coronary heart disease.
Topics: Adult; Arterial Occlusive Diseases; Cerebrovascular Disorders; Cholesterol; Clinical Trials as Topic | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
Long-term use of probucol in the multifactorial primary prevention of vascular disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cerebrovascular Disorders; Cholesterol, HDL; C | 1986 |
Clofibrate for the treatment of occlusive cerebrovascular disease.
Topics: Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Humans; Middle Aged; P | 1972 |
7 other studies available for clofibrate and Brain Vascular Disorders
Article | Year |
---|---|
ATROMID-S AND ATROMID.
Topics: Androsterone; Arteriosclerosis; Butyrates; Cerebrovascular Disorders; Clofibrate; Coronary Disease; | 1964 |
Reduced incidence of cardiovascular complications and mortality in hyperlipoproteinemia (HLP) with effective lipid correction. The Dresden HLP study.
Topics: Adolescent; Adult; Cerebrovascular Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Combine | 1984 |
Cholesterol reduction and stroke.
Topics: Cerebrovascular Disorders; Cholesterol; Clofibrate; Humans; Male; Meta-Analysis as Topic; Middle Age | 1994 |
Platelet suppressing drugs in arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Humans; Myocardial | 1978 |
[Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
Topics: Angina Pectoris; Cerebrovascular Disorders; Cholesterol; Clofibrate; Delayed-Action Preparations; Fo | 1976 |
Hyperlipidemia: to treat or not to treat.
Topics: Cerebrovascular Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyper | 1975 |
[Gerontotherapy in a clinical sanatorium with Gerostop].
Topics: Aged; Calcium; Cerebrovascular Disorders; Clofibrate; Drug Combinations; Health Resorts; Humans; Nic | 1972 |